COMMUNIQUÉS West-GlobeNewswire

Niger becomes the first country in sub-Saharan Africa to eliminate the transmission of onchocerciasis
30/01/2025
DECATUR, Ga., Jan. 30, 2025 (GLOBE NEWSWIRE) -- On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, commonly known as river [...]
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
30/01/2025
WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market opens on Thursday, [...]
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
30/01/2025
European patents expand coverage for both essential components of FemBloc for fallopian tube occlusion, resulting in non-surgical permanent contraception ATLANTA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq [...]
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
30/01/2025
SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
TOMI Environmental Reports Strong Start to 2025 with January Revenue Growth
30/01/2025
FREDERICK, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced positive [...]
Stereotaxis Announces First GenesisX Robotic System Order
30/01/2025
ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has received the first order [...]
Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
30/01/2025
CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates ( [...]
Liberation Labs Closes $50.5 Million Convertible Note
30/01/2025
Brings total deployable capital raised to date to $125 million and will enable completion of first biomanufacturing plant in Richmond, Indiana RICHMOND, Ind., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has closed [...]
Rentschler Biopharma announces strategic realignment of its global business operations
30/01/2025
LAUPHEIM, Germany, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its [...]
YuzuYello Named an Ad Age Best Place to Work 2025
28/01/2025
IPG Health agency honored with third recent noteworthy culture-focused award NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Yesterday, YuzuYello, an IPG Health company, announced that it has earned a top spot on Ad Age’s [...]
ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
28/01/2025
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief [...]
Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development
28/01/2025
Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2 Planned workforce reduction of approximately 40% of employees Corporate event to be held on [...]
Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business
28/01/2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers [...]
Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer
28/01/2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein’s decision follows an [...]
Stryker reports 2024 operating results and 2025 outlook
28/01/2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% to $6.4 billion [...]
Eyenovia Announces 1-for-80 Reverse Stock Split
28/01/2025
Reverse stock split, when effective, is intended to restore compliance with the Nasdaq minimum bid price requirement while Eyenovia continues to evaluate a broad range of strategic alternatives NEW YORK, Jan. 28, 2025 ( [...]
Ascentage Pharma Announces Closing of U.S. Initial Public Offering
28/01/2025
ROCKVILLE, Md. and SUZHOU, China, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the closing of its U.S. initial public offering of 7,325,000 American depositary shares (“ [...]
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update
28/01/2025
R eported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66 th American Society of Hematology Annual Meeting Received PRIME designation [...]
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
28/01/2025
The grant funding will further Tevogen Bio’s mission to develop therapies for treatment of cancers and viral infections. Tevogen Bio may also utilize the grant funding to further expand its artificial intelligence [...]

Pages